世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

生物製剤市場レポート:2025-2035

生物製剤市場レポート:2025-2035


Biologics Market Report 2025-2035

概要 生物製剤市場レポート 2025-2035: 本レポートは、業界とその基礎となる原動力をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなる。異業種への進出や新規地... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Visiongain
ヴィジョンゲイン社
2025年3月31日 GBP5,150
電子ファイル
ライセンス・価格情報
注文方法はこちら
2営業日程度 367 英語

※上記価格は部署ライセンス(Departmental licence)価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

概要

生物製剤市場レポート 2025-2035: 本レポートは、業界とその基礎となる原動力をよりよく理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなる。異業種への進出や新規地域での既存事業の拡大を目指す企業にも有用です。

生物製剤への需要の高まりが市場成長を後押し

生物製剤への需要の高まりは、2025年現在も医薬品市場成長の重要な原動力となっている。生物学的製剤(生物に由来する療法)は、特定の分子や細胞を標的にする精度の高さで知られ、副作用を抑えた効果的な治療につながる。この精度の高さにより、がん、自己免疫疾患、希少遺伝病などの複雑な病状に対処する上で特に価値がある。

最近の進歩は、生物製剤の治療用途を広げている。例えば2024年12月、米国食品医薬品局はネムルビオ(ネモリズマブ・イルト)を承認した。ガルデルマ社が開発したIL-31阻害剤である生物学的製剤で、12歳以上の中等度から重度のアトピー性皮膚炎患者を対象としています。今回の承認により、この慢性皮膚疾患の治療に新たな選択肢が加わることになる。

市場調査レポートを購入する前にすべき質問とは?

  • 生物製剤市場はどのように進化しているのか?
  • 何が生物製剤市場を牽引し、阻害しているのか?
  • 生物製剤の各サブ市場は予測期間中にどのように成長し、2035年にはどれくらいの売上を占めるようになるのか?
  • 2025年から2035年にかけて、各生物製剤サブマーケットの市場シェアはどのように推移するのか?
  • 2025年から2035年にかけて、市場全体を牽引する主な要因は何か?
  • 主要な生物製剤市場はマクロ経済の動きに幅広く追随するのか、それとも個々の国市場が他を凌駕するのか。
  • 2035年までに各国市場のシェアはどのように変化し、どの地域が2035年の市場をリードするのか。
  • 主要プレーヤーと予測期間中の見通しは?
  • これらの大手企業の生物製剤プロジェクトとは?
  • 2025年から2035年にかけて、業界はどのように発展していくのか?現在、そして今後10年間に行われる生物製剤プロジェクトにはどのような意味があるのか?
  • 生物製剤市場をさらに拡大するために、製品化の必要性は高まっているのだろうか?
  • 生物製剤市場はどこに向かっているのか、そしてどのようにすれば市場の最前線に立てるのか。
  • 新商品や新サービスに最適な投資方法とは?
  • 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは?

このことが、現在、そして今後10年間の生物製剤市場にどのような影響を与えるかを見極める必要がある:

  • 367ページにわたる本レポートでは、136の表と228の図表を掲載しています。
  • 本レポートでは、業界における主要な有利分野を取り上げているため、今すぐターゲットを絞ることができます。
  • 本レポートには、世界、地域、国の売上と成長に関する詳細な分析が含まれています。
  • 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

2035年までの予測やその他の分析から、商業的な展望が見えてきた

  • 2035年までの収益予測に加え、最新の実績、成長率、市場シェアもご覧いただけます。
  • ビジネスの展望や展開など、独自の分析が掲載されている。
  • 定性的分析(市場ダイナミクス、促進要因、機会、阻害要因、課題を含む)、コスト構造、生物製剤価格上昇の影響、最近の動向をご覧いただけます。

レポート対象セグメント

製品

・モノクローナル抗体
– ヒト
– ヒト化
– キメラ
– マウス
・ワクチン
・組み換えタンパク質
・再生医療
– 組織工学製品
– 細胞療法
– 遺伝子治療
・その他

用途

  • 腫瘍学
  • 感染症
  • 自己免疫疾患
  • 血液疾患
  • 心血管疾患
  • その他

製造タイプ

  • アウトソース
  • インハウス

ソース

  • 哺乳類
  • 微生物
  • その他

エンドユーザー

  • 病院
  • 専門センター
  • その他

世界市場全体と各分野の収益予測に加え、5つの地域と24の主要国市場の収益予測も掲載している:

北米

  • 米国
  • カナダ

欧州

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • ロシア
  • その他の欧州地域

アジア太平洋

  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • 東南アジア
  • その他のアジア太平洋地域

ラテンアメリカ

  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • その他のラテンアメリカ地域

MEA

  • GCC
  • 南アフリカ
  • その他のMEA地域

生物製剤市場レポート 2025-2035

本レポートには、2025年から2035年までの生物製剤市場における主要企業のプロファイルも掲載されている。

主要企業と市場成長の可能性

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Celltrion, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Merck & Co.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi

2025年から2035年までの生物製剤市場全体の世界売上高(金額ベース)は、2025年に4,500億米ドルを突破する。2035年まで力強い収益成長を予測している。当社の調査では、最も大きな可能性を秘めた組織を特定している。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。

生物製剤市場、2025-2035年レポートはどのように役立つのか?

要約すると、360ページを超えるレポートでは、以下のような知識を得ることができる:

  • 生物製剤市場の2025年から2035年までの収益予測、製品、用途、製造タイプ、供給元、エンドユーザーごとの予測を世界レベルと地域レベルで掲載 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。
  • 5つの地域と24の主要国市場の2035年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの生物製剤市場の2025年から2035年までの予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要国の市場も予測しています。
  • 2025年から2035年までの生物製剤市場に関わる主要企業16社の企業プロファイルを含む。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を入手しましょう。



ページTOPに戻る


目次

1 レポート概要
1.1 研究の目的
1.2 生物製剤市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通り:
1.6 本レポートは誰のためのものか?
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問(FAQ)
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.3 影響分析
3.3.1 市場促進要因
3.3.1.1 生物製剤に対する需要の高まり
3.3.1.2 生物医学の進歩
3.3.1.3 バイオ医薬品R&Dへの投資の増加
3.3.1.4 慢性疾患の有病率の上昇
3.3.1.5 高齢者人口の増加が市場成長を促進する
3.3.2 市場抑制要因
3.3.2.1 高い製造コスト
3.3.2.2 生物製剤開発における免疫原性と副作用のナビゲート
3.3.2.3 臨床試験の厳しさと回転率の低さ
3.3.3 市場機会
3.3.3.1 生物製剤における合併、買収、提携
3.3.3.2 生物製剤の承認と上市の急増
3.3.3.3 バイオ医薬品業務のCROへのアウトソーシングの増加
3.3.3.4 新興国におけるR&Dの拡大と優先順位付け
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの力
3.4.2 バイヤーパワー
3.4.3 競争力
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
3.6 現代医療における生物製剤の台頭
3.6.1 消化器疾患治療の新たなフロンティアを切り開く
3.6.2 変貌する食物アレルギー治療
3.6.3 生物製剤の課題:生産とデリバリー
3.6.4 未来は明るい
3.6.5 プレシジョン・メディシン:次のフロンティア
3.6.6 薬物送達技術の進歩
3.6.7 生物製剤の未来を楽観と意識でナビゲートする
3.7 生物製剤製造のライフサイクルをナビゲートする:前臨床から臨床へ
3.7.1 生物製剤の前臨床開発から臨床製造までの道のり
3.7.2 生物製剤の前臨床開発から臨床製造への旅はどのようなものか?
3.7.3 前臨床開発から臨床製造への移行における主な課題
3.7.4 生物製剤製造を形成するイノベーションと新たなトレンド
3.7.5 生物製剤開発に着手するチームへのアドバイス

4 生物製剤市場分析:製品別
4.1 主要な調査結果
4.2 製品セグメント 市場魅力度指数
4.3 製品別生物製剤市場規模の推定と予測
4.4 モノクローナル抗体
4.4.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
4.4.2 地域別市場シェア、2025年・2035年(%)
4.4.3 ヒト
4.4.3.1 2025〜2035年の地域別市場規模(10億米ドル)
4.4.3.2 地域別市場シェア、2025年・2035年(%)
4.4.4 ヒト化
4.4.4.1 2025〜2035年の地域別市場規模(10億米ドル)
4.4.4.2 地域別市場シェア、2025年・2035年(%)
4.4.5 キメラ
4.4.5.1 2025〜2035年の地域別市場規模(10億米ドル)
4.4.5.2 地域別市場シェア、2025年・2035年(%)
4.4.6 マウス
4.4.6.1 2025〜2035年の地域別市場規模(10億米ドル)
4.4.6.2 地域別市場シェア、2025年・2035年(%)
4.5 ワクチン
4.5.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
4.5.2 地域別市場シェア、2025年・2035年(%)
4.6 組換えタンパク質
4.6.1 2025~2035年の地域別市場予測(10億米ドル、AGR %)
4.6.2 地域別市場シェア、2025年・2035年(%)
4.7 再生医療
4.7.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
4.7.2 地域別市場シェア、2025年・2035年(%)
4.7.3 組織工学製品
4.7.3.1 2025~2035年の地域別市場規模(10億米ドル)
4.7.3.2 地域別市場シェア、2024年・2034年(%)
4.7.4 細胞療法
4.7.4.1 2025~2035年の地域別市場規模(10億米ドル)
4.7.4.2 地域別市場シェア、2024年・2034年(%)
4.7.5 遺伝子治療薬
4.7.5.1 2025〜2035年の地域別市場規模(10億米ドル)
4.7.5.2 2024年および2034年の地域別市場シェア(%)
4.8 その他
4.8.1 地域別市場予測、2025年〜2035年(10億米ドル、AGR %)
4.8.2 地域別市場シェア、2025年・2035年(%)

5 生物製剤市場分析:ソース別
5.1 主な調査結果
5.2 医薬品源セグメント 市場魅力度指数
5.3 生物製剤の供給源別市場規模の推定と予測
5.4 哺乳類
5.4.1 地域別市場予測、2025〜2035年(10億米ドル、AGR %)
5.4.2 地域別市場シェア、2025年・2035年(%)
5.5 微生物
5.5.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
5.5.2 地域別市場シェア、2025年・2035年(%)
5.6 その他
5.6.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
5.6.2 地域別市場シェア、2025年・2035年(%)

6 生物製剤市場分析:用途別
6.1 主要な調査結果
6.2 アプリケーションセグメント 市場魅力度指数
6.3 生物製剤の用途別市場規模推定と予測
6.4 がん領域
6.4.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
6.4.2 地域別市場シェア、2025年・2035年(%)
6.5 感染症
6.5.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
6.5.2 2025年および2035年の地域別市場シェア(%)
6.6 自己免疫疾患
6.6.1 地域別市場予測、2025〜2035年(10億米ドル、AGR %)
6.6.2 地域別市場シェア、2025年・2035年(%)
6.7 血液疾患
6.7.1 2025〜2035年の地域別市場予測(10億米ドル、AGR)
6.7.2 地域別市場シェア、2025年・2035年(%)
6.8 循環器疾患
6.8.1 2025〜2035年の地域別市場予測(10億米ドル、AGR)
6.8.2 地域別市場シェア、2025年・2035年(%)
6.9 その他
6.9.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
6.9.2 地域別市場シェア、2025年・2035年(%)

7 生物製剤市場分析:製造タイプ別
7.1 主要な調査結果
7.2 製造タイプ別セグメント 市場魅力度指数
7.3 製造タイプ別生物製剤市場規模の推定と予測
7.4 アウトソース
7.4.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
7.4.2 地域別市場シェア、2025年・2035年(%)
7.5 インハウス
7.5.1 2025年~2035年の地域別市場予測(10億米ドル、AGR %)
7.5.2 地域別市場シェア、2025年・2035年(%)

8 生物製剤市場分析:エンドユーザー別
8.1 主要な調査結果
8.2 エンドユーザー区分: 市場魅力度指数
8.3 エンドユーザー別生物製剤市場規模の推定と予測
8.4 病院
8.4.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
8.4.2 地域別市場シェア、2025年・2035年(%)
8.5 専門センター
8.5.1 地域別市場予測、2025~2035年(10億米ドル、AGR %)
8.5.2 地域別市場シェア、2025年・2035年(%)
8.6 その他
8.6.1 2025〜2035年の地域別市場予測(10億米ドル、AGR %)
8.6.2 地域別市場シェア、2025年・2035年(%)

9 生物製剤市場分析:地域別
9.1 主要な調査結果
9.2 地域別市場規模の推定と予測

10 北米の生物製剤市場分析
10.1 主要な調査結果
10.2 北米の生物製剤市場魅力度指数
10.3 北米の生物製剤市場:国別、2025年、2030年、2035年(10億米ドル)
10.4 北米の生物製剤の国別市場規模推定と予測
10.5 北米の生物製剤市場規模推定と予測:製品別
10.6 北米の生物製剤市場規模推定と予測:ソース別
10.7 北米の生物製剤市場規模推定と予測:用途別
10.8 生物製剤の北米市場規模推定と予測:製造タイプ別
10.9 北米の生物製剤市場規模推定と予測:エンドユーザー別
10.10 米国の生物製剤市場分析
10.11 カナダの生物製剤市場の分析

11 欧州の生物製剤市場分析
11.1 主要な調査結果
11.2 欧州の生物製剤市場魅力度指数
11.3 欧州の生物製剤の国別市場規模、2025年、2030年、2035年(10億米ドル)
11.4 欧州の生物製剤の国別市場規模推定と予測
11.5 欧州の生物製剤市場規模推定と予測:製品別
11.6 欧州の生物製剤市場規模推定と予測:ソース別
11.7 欧州の生物製剤市場規模推定と予測:用途別
11.8 欧州の生物製剤市場規模推定と予測:製造タイプ別
11.9 欧州の生物製剤市場規模推定と予測:エンドユーザー別
11.10 ドイツの生物製剤市場分析
11.11 イギリス生物製剤市場の分析
11.12 フランス生物製剤市場の分析
11.13 イタリアの生物製剤市場の分析
11.14 スペインの生物製剤市場の分析
11.15 ロシアの生物製剤市場の分析
11.16 その他の欧州の生物製剤市場の分析

12 アジア太平洋地域の生物製剤市場分析
12.1 主要な調査結果
12.2 アジア太平洋地域の生物製剤市場魅力度指数
12.3 アジア太平洋地域の生物製剤の国別市場、2025年、2030年、2035年(10億米ドル)
12.4 アジア太平洋地域の生物製剤の国別市場規模推定と予測
12.5 アジア太平洋地域の生物製剤市場規模推定と予測:製品別
12.6 アジア太平洋地域の生物製剤市場規模推定と予測:ソース別
12.7 アジア太平洋地域の生物製剤市場規模推定と予測:用途別
12.8 アジア太平洋地域の生物製剤市場規模推定と予測:製造タイプ別
12.9 アジア太平洋地域の生物製剤市場規模推定と予測:エンドユーザー別
12.10 日本の生物製剤市場の分析
12.11 中国の生物製剤市場の分析
12.12 インド生物製剤市場の分析
12.13 オーストラリア生物製剤市場の分析
12.14 韓国の生物製剤市場の分析
12.15 東南アジアの生物製剤市場の分析
12.16 その他のアジア太平洋地域の生物製剤市場の分析

13 ラテンアメリカの生物製剤市場分析
13.1 主要な調査結果
13.2 ラテンアメリカの生物製剤市場魅力度指数
13.3 ラテンアメリカの生物製剤市場の国別推移、2025年、2030年、2035年 (10億米ドル)
13.4 ラテンアメリカの生物製剤の国別市場規模推定と予測
13.5 ラテンアメリカの生物製剤市場規模推定と予測:製品別
13.6 ラテンアメリカの生物製剤市場規模推定と予測:ソース別
13.7 ラテンアメリカの生物製剤市場規模推定と予測:用途別
13.8 ラテンアメリカの生物製剤市場規模推定と予測:製造タイプ別
13.9 ラテンアメリカの生物製剤市場規模推定と予測:エンドユーザー別
13.10 ブラジルの生物製剤市場分析
13.11 メキシコ生物製剤市場の分析
13.12 アルゼンチンの生物製剤市場の分析
13.13 コロンビアの生物製剤市場の分析
13.14 その他のラテンアメリカの生物製剤市場の分析

14 MEAの生物製剤市場の分析
14.1 主要な調査結果
14.2 MEAの生物製剤市場魅力度指数
14.3 MEAの生物製剤の国別市場規模、2025年、2030年、2035年(10億米ドル)
14.4 MEAの生物製剤の国別市場規模推定と予測
14.5 MEAの生物製剤市場規模推定と予測:製品別
14.6 MEAの生物製剤市場規模推定と予測:ソース別
14.7 MEAの生物製剤市場規模推定と予測:用途別
14.8 MEAの生物製剤市場規模推定と予測:製造タイプ別
14.9 MEAの生物製剤市場規模推定と予測:エンドユーザー別
14.10 GCCの生物製剤市場分析
14.11 南アフリカの生物製剤市場の分析
14.12 その他のMEA生物製剤市場の分析

15 会社概要
15.1 競争環境
15.2 Johnson & Johnson
15.2.1 会社概要
15.2.2 会社概要
15.2.3 財務分析
15.2.3.1 純収入,2019-2024
15.2.3.2 売上高、2019-2024年
15.2.3.3 地域市場シェア(2024年
15.2.3.4 事業市場シェア(2024年
15.2.4 製品ベンチマーク
15.2.5 戦略的展望
15.3 F. Hoffmann-La Roche AG
15.3.1 会社概要
15.3.2 会社概要
15.3.3 財務分析
15.3.3.1 純収入、2019-2024年
15.3.3.2 R&D、2019-2024年
15.3.3.3 事業市場シェア、2024年
15.3.4 製品ベンチマーク
15.3.5 戦略的展望
15.4 Amgen Inc.
15.4.1 会社概要
15.4.2 会社概要
15.4.3 財務分析
15.4.3.1 純収入、2019-2024年
15.4.3.2 R&D、2019-2024年
15.4.3.3 地域市場シェア、2024年
15.4.3.4 事業市場シェア、2024年
15.4.4 製品ベンチマーク
15.4.5 戦略的展望
15.5 AbbVie Inc.
15.5.1 会社概要
15.5.2 会社概要
15.5.3 財務分析
15.5.3.1 純収入、2019-2024年
15.5.3.2 R&D、2019-2024年
15.5.3.3 地域市場シェア、2024年
15.5.3.4 事業市場シェア、2024年
15.5.4 製品ベンチマーク
15.5.5 戦略的展望
15.6 Novo Nordisk A/S
15.6.1 会社概要
15.6.2 会社概要
15.6.3 財務分析
15.6.3.1 純収入、2019-2024年
15.6.3.2 R&D、2019-2024年
15.6.3.3 地域市場シェア、2024年
15.6.3.4 事業市場シェア、2024年
15.6.4 製品ベンチマーク
15.6.5 戦略的展望
15.7 Eli Lilly and Company
15.7.1 会社概要
15.7.2 会社概要
15.7.3 財務分析
15.7.3.1 純収入、2019-2024年
15.7.3.2 R&D、2019-2024年
15.7.3.3 地域市場シェア、2024年
15.7.4 製品ベンチマーク
15.7.5 戦略的展望
15.8 Bristol-Myers Squibb Company
15.8.1 会社概要
15.8.2 会社概要
15.8.3 財務分析
15.8.3.1 純収入、2019-2024年
15.8.3.2 R&D、2019-2024年
15.8.3.3 地域市場シェア、2024年
15.8.4 製品ベンチマーク
15.8.5 戦略的展望
15.9 Merck & Co.
15.9.1 会社概要
15.9.2 会社概要
15.9.3 財務分析
15.9.3.1 純収入、2019-2024年
15.9.3.2 売上高、2019-2024年
15.9.3.3 地域市場シェア、2024年
15.9.3.4 事業市場シェア、2024年
15.9.4 製品ベンチマーク
15.9.5 戦略的展望
15.10 AstraZeneca plc
15.10.1 会社概要
15.10.2 会社概要
15.10.3 財務分析
15.10.3.1 純収入、2019-2024年
15.10.3.2 R&D、2019年〜2024年
15.10.3.3 地域市場シェア、2024年
15.10.4 製品ベンチマーク
15.10.5 戦略的展望
15.11 Sanofi
15.11.1 会社概要
15.11.2 会社概要
15.11.3 財務分析
15.11.3.1 純収入、2019-2024年
15.11.3.2 R&D、2019-2024年
15.11.3.3 地域市場シェア、2024年
15.11.4 製品ベンチマーク
15.11.5 戦略的展望
15.12 Pfizer Inc.
15.12.1 会社概要
15.12.2 会社概要
15.12.3 財務分析
15.12.3.1 純収入、2019-2024年
15.12.3.2 R&D、2019-2024年
15.12.3.3 地域市場シェア、2024年
15.12.3.4 事業市場シェア、2024年
15.12.4 製品ベンチマーク
15.12.5 戦略的展望
15.13 Regeneron Pharmaceuticals, Inc.
15.13.1 会社概要
15.13.2 会社概要
15.13.3 財務分析
15.13.3.1 純収入,2019-2024
15.13.3.2 売上高,2019-2024
15.13.4 製品ベンチマーク
15.13.5 戦略的展望
15.14 Gilead Sciences, Inc.
15.14.1 会社概要
15.14.2 会社概要
15.14.3 財務分析
15.14.3.1 純収入,2019-2024
15.14.3.2 売上高、2019-2024年
15.14.3.3 地域市場シェア(2024年
15.14.3.4 事業市場シェア(2024年
15.14.4 製品ベンチマーク
15.14.5 戦略的展望
15.15 Celltrion, Inc.
15.15.1 会社概要
15.15.2 会社概要
15.15.3 製品ベンチマーク
15.15.4 戦略的展望
15.16 Biogen Inc.
15.16.1 会社概要
15.16.2 会社概要
15.16.3 財務分析
15.16.3.1 純収入、2019-2024年
15.16.3.2 R&D、2019-2024年
15.16.3.3 地域市場シェア、2024年
15.16.4 製品ベンチマーク
15.16.5 戦略的展望
15.17 GSK plc
15.17.1 会社概要
15.17.2 会社概要
15.17.3 財務分析
15.17.3.1 純収入,2019-2024
15.17.3.2 売上高, 2019-2024
15.17.3.3 地域市場シェア(2024年
15.17.3.4 事業市場シェア(2024年
15.17.4 製品ベンチマーク
15.17.5 戦略的展望

16 結論と提言
16.1 Visiongainの結語
16.2 市場プレイヤーへの提言

ページTOPに戻る



図表リスト

List of Tables
Table 1 FDA Approved Cellular & Gene Therapies in 2024
Table 2 Biologics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 3 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 4 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 5 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 6 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 21 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 28 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 32 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 33 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 34 Biologics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 45 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 46 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 47 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 51 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 52 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 53
Table 54 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 57 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 58 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 59 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 60 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 63 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 64 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 65 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 69 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 74 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 75 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 77 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 78 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 79 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 80 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 81 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 82 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 83 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 84 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 85 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 86 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 87 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 88 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 89 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Johnson & Johnson: Product Benchmarking
Table 91 Johnson & Johnson: Strategic Outlook
Table 92 F. Hoffmann-La Roche AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 F. Hoffmann-La Roche AG: Product Benchmarking
Table 94 F. Hoffmann-La Roche AG: Strategic Outlook
Table 95 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Amgen Inc.: Product Benchmarking
Table 97 Amgen Inc. Strategic Outlook
Table 98 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 AbbVie Inc.: Product Benchmarking
Table 100 AbbVie Inc.: Strategic Outlook
Table 101 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Novo Nordisk A/S: Product Benchmarking
Table 103 Novo Nordisk A/S Strategic Outlook
Table 104 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Eli Lilly and Company: Product Benchmarking
Table 106 Eli Lilly and Company Strategic Outlook
Table 107 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Bristol-Myers Squibb Company: Product Benchmarking
Table 109 Bristol-Myers Squibb Company Strategic Outlook
Table 110 Merck & Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Merck & Co.: Product Benchmarking
Table 112 Merck & Co.: Strategic Outlook
Table 113 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 AstraZeneca plc: Product Benchmarking
Table 115 AstraZeneca plc Strategic Outlook
Table 116 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Sanofi: Product Benchmarking
Table 118 Sanofi Strategic Outlook
Table 119 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Pfizer Inc.: Product Benchmarking
Table 121 Pfizer Inc.: Strategic Outlook
Table 122 Regeneron Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Regeneron Pharmaceuticals, Inc.: Product Benchmarking
Table 124 Regeneron Pharmaceuticals, Inc.: Strategic Outlook
Table 125 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Gilead Sciences, Inc.: Product Benchmarking
Table 127 Gilead Sciences, Inc.: Strategic Outlook
Table 128 Celltrion, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Celltrion, Inc.: Product Benchmarking
Table 130 Celltrion, Inc. Strategic Outlook
Table 131 Biogen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Biogen Inc.: Product Benchmarking
Table 133 Biogen Inc. Strategic Outlook
Table 134 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 GSK plc: Product Benchmarking
Table 136 GSK plc: Strategic Outlook

List of Figures
Figure 1 Biologics Market Segmentation
Figure 2 Biologics Market by Product: Market Attractiveness Index
Figure 3 Biologics Market by Source: Market Attractiveness Index
Figure 4 Biologics Market by Application: Market Attractiveness Index
Figure 5 Biologics Market by Manufacturing Type: Market Attractiveness Index
Figure 6 Biologics Market by End-users: Market Attractiveness Index
Figure 7 Biologics Market Attractiveness Index by Region
Figure 8 Biologics Market: Market Dynamics
Figure 9 Biologics Market: Impact Analysis
Figure 10 Projected Number of People Aged 65 Years and Older
Figure 11 Biologics Market: Porter’s Five Forces Analysis
Figure 12 Biologics Market: PEST Analysis
Figure 13 Biologics Market Attractiveness Index by Product
Figure 14 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 15 Biologics Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 16 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 17 Monoclonal Antibodies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 Human Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 21 Humanized Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 23 Chimeric Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 Murine Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 27 Vaccines Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 28 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Recombinant Proteins Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Regenerative Medicine Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 Tissue Engineered Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Cell Therapy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 37 Gene Therapies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Biologics Market Attractiveness Index by Product
Figure 41 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 42 Biologics Market Share Forecast by Source, 2025, 2030, 2035 (%)
Figure 43 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Microbial Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Biologics Market Attractiveness Index by Application
Figure 50 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 51 Biologics Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 52 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 53 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 54 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 55 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 56 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 57 Autoimmune Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 58 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 59 Haematological Disorder Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 60 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 61 Cardiovascular Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 62 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 63 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 64 Biologics Market Attractiveness Index by Manufacturing Type
Figure 65 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 66 Biologics Market Share Forecast by Manufacturing Type, 2025, 2030, 2035 (%)
Figure 67 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 68 Outsource Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 69 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 70 In-house Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 71 Biologics Market Attractiveness Index by End-users
Figure 72 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 73 Biologics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 74 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 75 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 76 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 77 Speciality Centres Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 78 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 79 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 80 Biologics Market Forecast by Region 2025 & 2035 (Revenue, CAGR%)
Figure 81 Biologics Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 82 Biologics Market by Region, 2025-2035 (US$ Mn)
Figure 83 North America Biologics Market Attractiveness Index
Figure 84 North America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 85 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 87 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 88 North America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 89 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 90 North America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 91 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 92 North America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 93 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 94 North America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 95 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 96 North America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 97 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 Europe Biologics Market Attractiveness Index
Figure 100 Europe Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 Europe Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 104 Europe Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 105 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 106 Europe Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 107 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 108 Europe Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 109 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 110 Europe Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 111 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 112 Europe Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 113 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 114 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 115 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 116 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 117 Spain Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 118 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 119 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 Asia Pacific Biologics Market Attractiveness Index
Figure 121 Asia Pacific Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 122 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 123 Asia Pacific Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 124 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 125 Asia Pacific Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 126 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 127 Asia Pacific Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 128 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 129 Asia Pacific Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 130 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 131 Asia Pacific Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 132 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 133 Asia Pacific Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 134 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 135 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 136 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 140 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 141 Latin America Biologics Market Attractiveness Index
Figure 142 Latin America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 143 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 144 Latin America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 145 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 146 Latin America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 147 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 148 Latin America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 149 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 150 Latin America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 151 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 152 Latin America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 153 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 154 Latin America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 155 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 156 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 157 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 158 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 159 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 160 MEA Biologics Market Attractiveness Index
Figure 161 MEA Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 162 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 163 MEA Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 164 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 165 MEA Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 166 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 167 MEA Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 168 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 169 MEA Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 170 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 171 MEA Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 172 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 173 MEA Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 174 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 175 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 176 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 177 Johnson & Johnson: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 178 Johnson & Johnson: R&D, 2019-2024 (US$ Million, AGR%)
Figure 179 Johnson & Johnson: Regional Market Shares, 2024
Figure 180 Johnson & Johnson: Business Market Shares, 2024
Figure 181 F. Hoffmann-La Roche AG: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 182 F. Hoffmann-La Roche AG: R&D, 2019-2024 (US$ Million, AGR%)
Figure 183 F. Hoffmann-La Roche AG: Business Market Shares, 2024
Figure 184 Amgen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 185 Amgen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 186 Amgen Inc.: Regional Market Shares, 2024
Figure 187 Amgen Inc.: Business Market Shares, 2024
Figure 188 AbbVie Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 189 AbbVie Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 190 AbbVie Inc.: Regional Market Shares, 2024
Figure 191 AbbVie Inc.: Business Market Shares, 2024
Figure 192 Novo Nordisk A/S: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 193 Novo Nordisk A/S: R&D, 2019-2024 (US$ Million, AGR%)
Figure 194 Novo Nordisk A/S: Regional Market Shares, 2024
Figure 195 Novo Nordisk A/S: Business Market Shares, 2024
Figure 196 Eli Lilly and Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 197 Eli Lilly and Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 198 Eli Lilly and Company: Regional Market Shares, 2024
Figure 199 Bristol-Myers Squibb Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 200 Bristol-Myers Squibb Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 201 Bristol-Myers Squibb Company: Regional Market Shares, 2024
Figure 202 Merck & Co.: Net Revenue, 2019-2024(US$ Million, AGR%)
Figure 203 Merck & Co.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 204 Merck & Co.: Regional Market Shares, 2024
Figure 205 Merck & Co.: Business Market Shares, 2024
Figure 206 AstraZeneca plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 207 AstraZeneca plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 208 AstraZeneca plc: Regional Market Shares, 2024
Figure 209 Sanofi: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 210 Sanofi: R&D, 2019-2024 (US$ Million, AGR%)
Figure 211 Sanofi: Regional Market Shares, 2024
Figure 212 Pfizer Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 213 Pfizer Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 214 Pfizer Inc.: Regional Market Shares, 2024
Figure 215 Pfizer Inc.: Business Market Shares, 2024
Figure 216 Regeneron Pharmaceuticals, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 217 Regeneron Pharmaceuticals, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 218 Gilead Sciences, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 219 Gilead Sciences, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 220 Gilead Sciences, Inc.: Regional Market Shares, 2024
Figure 221 Gilead Sciences, Inc: Business Market Shares, 2024
Figure 222 Biogen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 223 Biogen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 224 Biogen Inc.: Regional Market Shares, 2024
Figure 225 GSK plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 226 GSK plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 227 GSK plc: Regional Market Shares, 2024
Figure 228 GSK plc: Business Market Shares, 2024

 

ページTOPに戻る


 

Summary

Description

The Biologics Market Report 2025-2035: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Escalating Demand for Biologics is Boosting the Market Growth

The escalating demand for biologics continues to be a significant driver of growth in the pharmaceutical market as of 2025. Biologics—therapies derived from living organisms—are renowned for their precision in targeting specific molecules or cells, leading to effective treatments with reduced side effects. This precision makes them particularly valuable in addressing complex medical conditions such as cancer, autoimmune disorders, and rare genetic diseases.

Recent advancements have broadened the therapeutic applications of biologics. For instance, in December 2024, the U.S. Food and Drug Administration approved Nemluvio (nemolizumab-ilto), an IL-31 inhibitor biologic developed by Galderma, for individuals aged 12 and older with moderate to severe atopic dermatitis. This approval introduces a new option for managing this chronic skin condition.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the biologics market evolving?
  • What is driving and restraining the biologics market?
  • How will each biologics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each biologics submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading biologics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the biologics projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of biologics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the biologics market?
  • Where is the biologics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biologics market today, and over the next 10 years:

  • Our 367-page report provides 136 tables and 228 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biologics prices and recent developments.

Segments Covered in the Report

Product

  • Monoclonal Antibodies
    – Human
    – Humanized
    – Chimeric
    – Murine
  • Vaccines
  • Recombinant Proteins
  • Regenerative Medicine
    – Tissue Engineered Products
    – Cell Therapy
    – Gene Therapies
  • Others

Application

  • Oncology
  • Infectious Diseases
  • Autoimmune Disease
  • Haematological Disorder
  • Cardiovascular Disorders
  • Others

Manufacturing Type

  • Outsource
  • In-house

Source

  • Mammalian
  • Microbial
  • Others

End-users

  • Hospitals
  • Speciality Centres
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

Biologics Market Report 2025-2035

The report also includes profiles and for some of the leading companies in the Biologics Market, 2025 to 2035, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Celltrion, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Merck & Co.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi

Overall world revenue for Biologics Market, 2025 to 2035 in terms of value the market will surpass US$450.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biologics Market, 2025 to 2035 report help you?

In summary, our 360+ page report provides you with the following knowledge:

  • Revenue forecasts to 2035 for Biologics Market, 2025 to 2035, with forecasts for product, application, manufacturing type, source, and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 24 key national markets – See forecasts for the Biologics Market, 2025 to 2035 in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Biologics Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

 



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biologics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Rising Demand for Biologics
3.3.1.2 Advancements in Biomedical Science
3.3.1.3 Rising Investments in Biopharmaceutical R&D
3.3.1.4 Rising Prevalence of Chronic Diseases
3.3.1.5 Increase in Number of Elderly Population will Drive the Market Growth
3.3.2 Market Restraining Factors
3.3.2.1 High Production Costs
3.3.2.2 Navigating Immunogenicity and Adverse Reactions in Biologics Development
3.3.2.3 High Stringency and Low Turnover for Clinical Trials
3.3.3 Market Opportunities
3.3.3.1 Mergers, Acquisitions, and Collaborations in Biologics
3.3.3.2 Surging Drug Approvals and Launches of Biologics
3.3.3.3 Increasing Outsourcing of Biopharmaceutical Activities to CROs
3.3.3.4 Emerging Economies Expansion and Prioritisation of R&D
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.6 The Rise of Biologics in Modern Medicine
3.6.1 Navigating New Frontiers in GI Disease Treatment
3.6.2 Transforming Food Allergy Treatment
3.6.3 Challenges in Biologics: Production and Delivery
3.6.4 The Future Looks Bright
3.6.5 Precision Medicine: The Next Frontier
3.6.6 Advancing Drug Delivery Techniques
3.6.7 Navigating the Future of Biologics with Optimism and Awareness
3.7 Navigating the Biologics Manufacturing Lifecycle: From Preclinical to Clinical
3.7.1 The Journey from Preclinical Development to Clinical Manufacturing in Biologics
3.7.2 What Does the Biologics Journey from Preclinical Development to Clinical Manufacturing Look Like?
3.7.3 Key Challenges in the Transition from Preclinical Development to Clinical Manufacturing
3.7.4 Innovations and Emerging Trends Shaping Biologics Manufacturing
3.7.5 Advice for Teams Embarking on Biologics Development

4 Biologics Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Biologics Market Size Estimation and Forecast by Product
4.4 Monoclonal Antibodies
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.4.3 Human
4.4.3.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.3.2 Market Share by Region, 2024 & 2034 (%)
4.4.4 Humanized
4.4.4.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.4.2 Market Share by Region, 2024 & 2034 (%)
4.4.5 Chimeric
4.4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.5.2 Market Share by Region, 2024 & 2034 (%)
4.4.6 Murine
4.4.6.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.6.2 Market Share by Region, 2024 & 2034 (%)
4.5 Vaccines
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)
4.6 Recombinant Proteins
4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2025 & 2035 (%)
4.7 Regenerative Medicine
4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2025 & 2035 (%)
4.7.3 Tissue Engineered Products
4.7.3.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.3.2 Market Share by Region, 2024 & 2034 (%)
4.7.4 Cell Therapy
4.7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.4.2 Market Share by Region, 2024 & 2034 (%)
4.7.5 Gene Therapies
4.7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.7.5.2 Market Share by Region, 2024 & 2034 (%)
4.8 Others
4.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.8.2 Market Share by Region, 2025 & 2035 (%)

5 Biologics Market Analysis by Source
5.1 Key Findings
5.2 Source Segment: Market Attractiveness Index
5.3 Biologics Market Size Estimation and Forecast by Source
5.4 Mammalian
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Microbial
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Others
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)

6 Biologics Market Analysis by Application
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Biologics Market Size Estimation and Forecast by Application
6.4 Oncology
6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Infectious Diseases
6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Autoimmune Disease
6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Haematological Disorder
6.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Cardiovascular Disorders
6.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Others
6.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.9.2 Market Share by Region, 2025 & 2035 (%)

7 Biologics Market Analysis by Manufacturing Type
7.1 Key Findings
7.2 Manufacturing Type Segment: Market Attractiveness Index
7.3 Biologics Market Size Estimation and Forecast by Manufacturing Type
7.4 Outsource
7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 In-house
7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)

8 Biologics Market Analysis by End-users
8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Biologics Market Size Estimation and Forecast by End-users
8.4 Hospitals
8.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.4.2 Market Share by Region, 2025 & 2035 (%)
8.5 Speciality Centres
8.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.5.2 Market Share by Region, 2025 & 2035 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
8.6.2 Market Share by Region, 2025 & 2035 (%)

9 Biologics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Biologics Market Analysis
10.1 Key Findings
10.2 North America Biologics Market Attractiveness Index
10.3 North America Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 North America Biologics Market Size Estimation and Forecast by Country
10.5 North America Biologics Market Size Estimation and Forecast by Product
10.6 North America Biologics Market Size Estimation and Forecast by Source
10.7 North America Biologics Market Size Estimation and Forecast by Application
10.8 North America Biologics Market Size Estimation and Forecast by Manufacturing Type
10.9 North America Biologics Market Size Estimation and Forecast by End-users
10.10 U.S. Biologics Market Analysis
10.11 Canada Biologics Market Analysis

11 Europe Biologics Market Analysis
11.1 Key Findings
11.2 Europe Biologics Market Attractiveness Index
11.3 Europe Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 Europe Biologics Market Size Estimation and Forecast by Country
11.5 Europe Biologics Market Size Estimation and Forecast by Product
11.6 Europe Biologics Market Size Estimation and Forecast by Source
11.7 Europe Biologics Market Size Estimation and Forecast by Application
11.8 Europe Biologics Market Size Estimation and Forecast by Manufacturing Type
11.9 Europe Biologics Market Size Estimation and Forecast by End-users
11.10 Germany Biologics Market Analysis
11.11 UK Biologics Market Analysis
11.12 France Biologics Market Analysis
11.13 Italy Biologics Market Analysis
11.14 Spain Biologics Market Analysis
11.15 Russia Biologics Market Analysis
11.16 Rest of Europe Biologics Market Analysis

12 Asia Pacific Biologics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Biologics Market Attractiveness Index
12.3 Asia Pacific Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Asia Pacific Biologics Market Size Estimation and Forecast by Country
12.5 Asia Pacific Biologics Market Size Estimation and Forecast by Product
12.6 Asia Pacific Biologics Market Size Estimation and Forecast by Source
12.7 Asia Pacific Biologics Market Size Estimation and Forecast by Application
12.8 Asia Pacific Biologics Market Size Estimation and Forecast by Manufacturing Type
12.9 Asia Pacific Biologics Market Size Estimation and Forecast by End-users
12.10 Japan Biologics Market Analysis
12.11 China Biologics Market Analysis
12.12 India Biologics Market Analysis
12.13 Australia Biologics Market Analysis
12.14 South Korea Biologics Market Analysis
12.15 South-East Asia Biologics Market Analysis
12.16 Rest of Asia Pacific Biologics Market Analysis

13 Latin America Biologics Market Analysis
13.1 Key Findings
13.2 Latin America Biologics Market Attractiveness Index
13.3 Latin America Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 Latin America Biologics Market Size Estimation and Forecast by Country
13.5 Latin America Biologics Market Size Estimation and Forecast by Product
13.6 Latin America Biologics Market Size Estimation and Forecast by Source
13.7 Latin America Biologics Market Size Estimation and Forecast by Application
13.8 Latin America Biologics Market Size Estimation and Forecast by Manufacturing Type
13.9 Latin America Biologics Market Size Estimation and Forecast by End-users
13.10 Brazil Biologics Market Analysis
13.11 Mexico Biologics Market Analysis
13.12 Argentina Biologics Market Analysis
13.13 Colombia Biologics Market Analysis
13.14 Rest of Latin America Biologics Market Analysis

14 MEA Biologics Market Analysis
14.1 Key Findings
14.2 MEA Biologics Market Attractiveness Index
14.3 MEA Biologics Market by Country, 2025, 2030 & 2035 (US$ Billion)
14.4 MEA Biologics Market Size Estimation and Forecast by Country
14.5 MEA Biologics Market Size Estimation and Forecast by Product
14.6 MEA Biologics Market Size Estimation and Forecast by Source
14.7 MEA Biologics Market Size Estimation and Forecast by Application
14.8 MEA Biologics Market Size Estimation and Forecast by Manufacturing Type
14.9 MEA Biologics Market Size Estimation and Forecast by End-users
14.10 GCC Biologics Market Analysis
14.11 South Africa Biologics Market Analysis
14.12 Rest of MEA Biologics Market Analysis

15 Company Profiles
15.1 Competitive Landscape
15.2 Johnson & Johnson
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue,2019-2024
15.2.3.2 R&D,2019-2024
15.2.3.3 Regional Market Shares, 2024
15.2.3.4 Business Market Shares, 2024
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 F. Hoffmann-La Roche AG
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2019-2024
15.3.3.2 R&D, 2019-2024
15.3.3.3 Business Market Shares, 2024
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Amgen Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2019-2024
15.4.3.2 R&D, 2019-2024
15.4.3.3 Regional Market Shares, 2024
15.4.3.4 Business Market Shares, 2024
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 AbbVie Inc.
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2019-2024
15.5.3.2 R&D, 2019-2024
15.5.3.3 Regional Market Shares, 2024
15.5.3.4 Business Market Shares, 2024
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Novo Nordisk A/S
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2019-2024
15.6.3.2 R&D, 2019-2024
15.6.3.3 Regional Market Shares, 2024
15.6.3.4 Business Market Shares, 2024
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Eli Lilly and Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2019-2024
15.7.3.2 R&D, 2019-2024
15.7.3.3 Regional Market Shares, 2024
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Bristol-Myers Squibb Company
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2019-2024
15.8.3.2 R&D, 2019-2024
15.8.3.3 Regional Market Shares, 2024
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Merck & Co.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2019-2024
15.9.3.2 R&D, 2019-2024
15.9.3.3 Regional Market Shares, 2024
15.9.3.4 Business Market Shares, 2024
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 AstraZeneca plc
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2019-2024
15.10.3.2 R&D, 2019-2024
15.10.3.3 Regional Market Shares, 2024
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Sanofi
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2019-2024
15.11.3.2 R&D, 2019-2024
15.11.3.3 Regional Market Shares, 2024
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Pfizer Inc.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2019-2024
15.12.3.2 R&D, 2019-2024
15.12.3.3 Regional Market Shares, 2024
15.12.3.4 Business Market Shares, 2024
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Regeneron Pharmaceuticals, Inc.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue,2019-2024
15.13.3.2 R&D,2019-2024
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Gilead Sciences, Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue,2019-2024
15.14.3.2 R&D,2019-2024
15.14.3.3 Regional Market Shares, 2024
15.14.3.4 Business Market Shares, 2024
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Celltrion, Inc.
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Product Benchmarking
15.15.4 Strategic Outlook
15.16 Biogen Inc.
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2019-2024
15.16.3.2 R&D, 2019-2024
15.16.3.3 Regional Market Shares, 2024
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 GSK plc
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue,2019-2024
15.17.3.2 R&D,2019-2024
15.17.3.3 Regional Market Shares, 2024
15.17.3.4 Business Market Shares, 2024
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 FDA Approved Cellular & Gene Therapies in 2024
Table 2 Biologics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 3 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 4 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 5 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 6 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 21 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 28 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 32 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 33 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 34 Biologics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 45 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 46 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 47 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 51 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 52 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 53
Table 54 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 57 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 58 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 59 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 60 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 63 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 64 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 65 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 69 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 74 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 75 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 77 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 78 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 79 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 80 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 81 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 82 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 83 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 84 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 85 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 86 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 87 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 88 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 89 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Johnson & Johnson: Product Benchmarking
Table 91 Johnson & Johnson: Strategic Outlook
Table 92 F. Hoffmann-La Roche AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 F. Hoffmann-La Roche AG: Product Benchmarking
Table 94 F. Hoffmann-La Roche AG: Strategic Outlook
Table 95 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Amgen Inc.: Product Benchmarking
Table 97 Amgen Inc. Strategic Outlook
Table 98 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 AbbVie Inc.: Product Benchmarking
Table 100 AbbVie Inc.: Strategic Outlook
Table 101 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Novo Nordisk A/S: Product Benchmarking
Table 103 Novo Nordisk A/S Strategic Outlook
Table 104 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Eli Lilly and Company: Product Benchmarking
Table 106 Eli Lilly and Company Strategic Outlook
Table 107 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Bristol-Myers Squibb Company: Product Benchmarking
Table 109 Bristol-Myers Squibb Company Strategic Outlook
Table 110 Merck & Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Merck & Co.: Product Benchmarking
Table 112 Merck & Co.: Strategic Outlook
Table 113 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 AstraZeneca plc: Product Benchmarking
Table 115 AstraZeneca plc Strategic Outlook
Table 116 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Sanofi: Product Benchmarking
Table 118 Sanofi Strategic Outlook
Table 119 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Pfizer Inc.: Product Benchmarking
Table 121 Pfizer Inc.: Strategic Outlook
Table 122 Regeneron Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Regeneron Pharmaceuticals, Inc.: Product Benchmarking
Table 124 Regeneron Pharmaceuticals, Inc.: Strategic Outlook
Table 125 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Gilead Sciences, Inc.: Product Benchmarking
Table 127 Gilead Sciences, Inc.: Strategic Outlook
Table 128 Celltrion, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Celltrion, Inc.: Product Benchmarking
Table 130 Celltrion, Inc. Strategic Outlook
Table 131 Biogen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Biogen Inc.: Product Benchmarking
Table 133 Biogen Inc. Strategic Outlook
Table 134 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 GSK plc: Product Benchmarking
Table 136 GSK plc: Strategic Outlook

List of Figures
Figure 1 Biologics Market Segmentation
Figure 2 Biologics Market by Product: Market Attractiveness Index
Figure 3 Biologics Market by Source: Market Attractiveness Index
Figure 4 Biologics Market by Application: Market Attractiveness Index
Figure 5 Biologics Market by Manufacturing Type: Market Attractiveness Index
Figure 6 Biologics Market by End-users: Market Attractiveness Index
Figure 7 Biologics Market Attractiveness Index by Region
Figure 8 Biologics Market: Market Dynamics
Figure 9 Biologics Market: Impact Analysis
Figure 10 Projected Number of People Aged 65 Years and Older
Figure 11 Biologics Market: Porter’s Five Forces Analysis
Figure 12 Biologics Market: PEST Analysis
Figure 13 Biologics Market Attractiveness Index by Product
Figure 14 Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 15 Biologics Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 16 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 17 Monoclonal Antibodies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Human Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 Human Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Humanized Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 21 Humanized Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Chimeric Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 23 Chimeric Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Murine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 Murine Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 27 Vaccines Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 28 Recombinant Proteins Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Recombinant Proteins Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Regenerative Medicine Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Regenerative Medicine Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 Tissue Engineered Products Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 Tissue Engineered Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Cell Therapy Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Cell Therapy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 37 Gene Therapies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 Biologics Market Attractiveness Index by Product
Figure 41 Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 42 Biologics Market Share Forecast by Source, 2025, 2030, 2035 (%)
Figure 43 Mammalian Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Mammalian Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Microbial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Microbial Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Biologics Market Attractiveness Index by Application
Figure 50 Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 51 Biologics Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 52 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 53 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 54 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 55 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 56 Autoimmune Disease Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 57 Autoimmune Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 58 Haematological Disorder Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 59 Haematological Disorder Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 60 Cardiovascular Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 61 Cardiovascular Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 62 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 63 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 64 Biologics Market Attractiveness Index by Manufacturing Type
Figure 65 Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 66 Biologics Market Share Forecast by Manufacturing Type, 2025, 2030, 2035 (%)
Figure 67 Outsource Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 68 Outsource Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 69 In-house Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 70 In-house Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 71 Biologics Market Attractiveness Index by End-users
Figure 72 Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 73 Biologics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 74 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 75 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 76 Speciality Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 77 Speciality Centres Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 78 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 79 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 80 Biologics Market Forecast by Region 2025 & 2035 (Revenue, CAGR%)
Figure 81 Biologics Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 82 Biologics Market by Region, 2025-2035 (US$ Mn)
Figure 83 North America Biologics Market Attractiveness Index
Figure 84 North America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 85 North America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 87 North America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 88 North America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 89 North America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 90 North America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 91 North America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 92 North America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 93 North America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 94 North America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 95 North America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 96 North America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 97 U.S. Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Canada Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 Europe Biologics Market Attractiveness Index
Figure 100 Europe Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 Europe Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 Europe Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 Europe Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 104 Europe Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 105 Europe Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 106 Europe Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 107 Europe Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 108 Europe Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 109 Europe Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 110 Europe Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 111 Europe Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 112 Europe Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 113 Germany Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 114 UK Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 115 France Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 116 Italy Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 117 Spain Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 118 Russia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 119 Rest of Europe Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 Asia Pacific Biologics Market Attractiveness Index
Figure 121 Asia Pacific Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 122 Asia Pacific Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 123 Asia Pacific Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 124 Asia Pacific Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 125 Asia Pacific Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 126 Asia Pacific Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 127 Asia Pacific Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 128 Asia Pacific Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 129 Asia Pacific Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 130 Asia Pacific Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 131 Asia Pacific Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 132 Asia Pacific Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 133 Asia Pacific Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 134 Japan Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 135 China Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 136 India Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 Australia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 South Korea Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 South-East Asia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 140 Rest of Asia Pacific Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 141 Latin America Biologics Market Attractiveness Index
Figure 142 Latin America Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 143 Latin America Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 144 Latin America Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 145 Latin America Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 146 Latin America Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 147 Latin America Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 148 Latin America Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 149 Latin America Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 150 Latin America Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 151 Latin America Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 152 Latin America Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 153 Latin America Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 154 Latin America Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 155 Brazil Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 156 Mexico Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 157 Argentina Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 158 Colombia Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 159 Rest of Latin America Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 160 MEA Biologics Market Attractiveness Index
Figure 161 MEA Biologics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 162 MEA Biologics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 163 MEA Biologics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 164 MEA Biologics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 165 MEA Biologics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 166 MEA Biologics Market Forecast by Source, 2025-2035 (US$ Billion, AGR %)
Figure 167 MEA Biologics Market Share Forecast by Source, 2025 & 2035 (%)
Figure 168 MEA Biologics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 169 MEA Biologics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 170 MEA Biologics Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR %)
Figure 171 MEA Biologics Market Share Forecast by Manufacturing Type, 2025 & 2035 (%)
Figure 172 MEA Biologics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 173 MEA Biologics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 174 GCC Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 175 South Africa Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 176 Rest of MEA Biologics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 177 Johnson & Johnson: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 178 Johnson & Johnson: R&D, 2019-2024 (US$ Million, AGR%)
Figure 179 Johnson & Johnson: Regional Market Shares, 2024
Figure 180 Johnson & Johnson: Business Market Shares, 2024
Figure 181 F. Hoffmann-La Roche AG: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 182 F. Hoffmann-La Roche AG: R&D, 2019-2024 (US$ Million, AGR%)
Figure 183 F. Hoffmann-La Roche AG: Business Market Shares, 2024
Figure 184 Amgen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 185 Amgen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 186 Amgen Inc.: Regional Market Shares, 2024
Figure 187 Amgen Inc.: Business Market Shares, 2024
Figure 188 AbbVie Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 189 AbbVie Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 190 AbbVie Inc.: Regional Market Shares, 2024
Figure 191 AbbVie Inc.: Business Market Shares, 2024
Figure 192 Novo Nordisk A/S: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 193 Novo Nordisk A/S: R&D, 2019-2024 (US$ Million, AGR%)
Figure 194 Novo Nordisk A/S: Regional Market Shares, 2024
Figure 195 Novo Nordisk A/S: Business Market Shares, 2024
Figure 196 Eli Lilly and Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 197 Eli Lilly and Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 198 Eli Lilly and Company: Regional Market Shares, 2024
Figure 199 Bristol-Myers Squibb Company: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 200 Bristol-Myers Squibb Company: R&D, 2019-2024 (US$ Million, AGR%)
Figure 201 Bristol-Myers Squibb Company: Regional Market Shares, 2024
Figure 202 Merck & Co.: Net Revenue, 2019-2024(US$ Million, AGR%)
Figure 203 Merck & Co.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 204 Merck & Co.: Regional Market Shares, 2024
Figure 205 Merck & Co.: Business Market Shares, 2024
Figure 206 AstraZeneca plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 207 AstraZeneca plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 208 AstraZeneca plc: Regional Market Shares, 2024
Figure 209 Sanofi: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 210 Sanofi: R&D, 2019-2024 (US$ Million, AGR%)
Figure 211 Sanofi: Regional Market Shares, 2024
Figure 212 Pfizer Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 213 Pfizer Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 214 Pfizer Inc.: Regional Market Shares, 2024
Figure 215 Pfizer Inc.: Business Market Shares, 2024
Figure 216 Regeneron Pharmaceuticals, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 217 Regeneron Pharmaceuticals, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 218 Gilead Sciences, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 219 Gilead Sciences, Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 220 Gilead Sciences, Inc.: Regional Market Shares, 2024
Figure 221 Gilead Sciences, Inc: Business Market Shares, 2024
Figure 222 Biogen Inc.: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 223 Biogen Inc.: R&D, 2019-2024 (US$ Million, AGR%)
Figure 224 Biogen Inc.: Regional Market Shares, 2024
Figure 225 GSK plc: Net Revenue, 2019-2024 (US$ Million, AGR%)
Figure 226 GSK plc: R&D, 2019-2024 (US$ Million, AGR%)
Figure 227 GSK plc: Regional Market Shares, 2024
Figure 228 GSK plc: Business Market Shares, 2024

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(生物学的製剤)の最新刊レポート

本レポートと同じKEY WORD(biologics)の最新刊レポート


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社(Visiongain)は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/02 10:26

150.84 円

163.21 円

197.52 円

ページTOPに戻る